LONDON, Sept. 28, 2016 /PRNewswire/ -- This report analyzes the worldwide markets for Veterinary Vaccines in US$ by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 102 companies including many key and niche players such as -
Bayer HealthCare AG
Biogénesis Bagó
Boehringer Ingelheim GmbH
Ceva Santé Animale
Elanco Animal Health
Download the full report: https://www.reportbuyer.com/product/2070079/
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 A. Companion Animal Vaccines..............I-3 B. Livestock Vaccines..............I-4 Porcine Vaccines.............. I-4 Bovine Vaccines..............I-4 Poultry Vaccines.............. I-4 Ovine Vaccines.............. I-4 Equine Vaccines..............I-4 Other Animal Vaccines..............I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Market Outlook.............. II-1 Convergence of Factors Prime the Market for Sizable Growth II-2 Sizing the Global Veterinary Vaccines Market II-2 Table 1: Global Animal Health Products Market by Region (2015): Percentage Share Breakdown by Value Sales for Asia-Pacific, Europe, Latin America, North America and Rest of World (includes corresponding Graph/Chart) II-3
Table 2: Global Animal Health Products Market by Product Group (2015): Percentage Breakdown by Value Sales for Anti-Infectives, Medicinal Feed Additives, Parasiticides, Vaccines and Other Pharmaceuticals (includes corresponding Graph/Chart).............. II-3 Mature Markets Vis-a-vis Emerging Markets II-4 Veterinary Vaccines - A Highly Consolidated Market II-4 Scientific R&D - Crucial for Market Growth II-5 Market Challenges.............. II-5
2. MARKET TRENDS & ISSUES..............II-6 Need to Ensure Sustainable Food Supply Spurs Growth II-6 Increasing Demand for Animal Protein in Developing Countries to Benefit the Market..............II-6 Table 3: Projected Global Per Capita Consumption of Meat (in kg per year) by Geographic Region by the year 2030 (includes corresponding Graph/Chart)..............II-7
Table 4: Projected Global Consumption of Animal Products (in million tons) by Developing and Developed Countries for the year 2030 (includes corresponding Graph/Chart) II-7 Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine.............. II-8 Management of Emerging Diseases - A Case of Development and Demand Novel Vaccines..............II-8 Need to Safeguard Public Health Drives Interest in Veterinary Vaccines.............. II-8 Social Concerns on Slaughtering Presents a Valid Case for Use of Vaccines.............. II-8 Companion Animals: A Lucrative Market Segment II-9 Increasing Pet Ownership Drives Demand for Companion Animal Vaccines.............. II-9 Table 5: World Pet Dog Ownership (2016E): Top Ten Nations with Dog Population in Millions (includes corresponding Graph/Chart).............. II-10
Table 6: World Pet Cat Ownership (2016E): Top Ten Nations with Cat Population in Millions (includes corresponding Graph/Chart).............. II-10 Spread of Zoonotic Diseases Propels Growth II-11 Porcine Market Offers Significant Prospects for Growth and New Vaccine Development..............II-11 Select Key Marketed Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccines..............II-12 Porcine Epidemic Diarrhea Virus (PEDV) Vaccines Available in Select Countries..............II-13 Recombinant DNA Technology to Take Over the Industry II-13 Improvised Adjuvant Usage and Veterinary Vaccine Delivery Systems II-14 New Effervescent Tablets Vaccines against NDV - Augmenting Trend towards Convenient Administration II-15 One-Shot Vaccine against BVD - New Innovation Promises to Change Vaccination Paradigm..............II-16 Anthrax, Rabies, and Other Vaccines with Improved Adjuvants in the Pipeline.............. II-16 Global Efforts to Conquer FMD by an Effective Vaccine II-16 Developments in the Poultry Vaccine Market II-17 Vaccination - Critical for Controlling Avian Influenza Virus II-18 Parasitic Vaccines Segment Holds Potential II-18 Egg-Derived Veterinary Vaccines in Human Vaccine Facilities II-19 New Vaccines Strains - The Imminent Need in the Vaccine Market II-19 The Need for Innovative Vaccine Delivery Mechanism Increasing II-19 More Vaccines Needed to Prevent Zoonotic Infections II-19 Plant-based Vaccines - the Next Avenue in Cost-effective and Efficacious Vaccines; Obstacles Persist Delaying Market Debut II-20 Pricing Affects the Livestock Vaccine Market II-21 Over-Vaccination Trend May Prove Harmful II-21
3. PRODUCT OVERVIEW.............. II-22 Vaccines - An Evolutionary Scan..............II-22 Veterinary Medicines - A Brief Review II-22 Concept Development.............. II-23 Production of Vaccines..............II-23 Veterinary Vaccines - An Essential Component of Animal Healthcare II-24 What Does A Veterinary Vaccine Do? II-24 Classification of Veterinary Vaccines II-24 Companion Animal Vaccines..............II-24 Canine Vaccines.............. II-25 Canine Distemper.............. II-26 Canine Parvovirus..............II-26 Tracheobronchitis..............II-26 Canine Coronavirus..............II-26 Canine Leptospirosis..............II-26 Canine Giardia.............. II-26 Canine Lyme borreliosis..............II-26 Canine Rabies.............. II-26 Feline Vaccines.............. II-27 Feline Panleukopenia Virus Vaccine II-27 Feline Calicivirus & Herpesvirus Vaccine II-27 Rabies Virus Vaccine..............II-27 Feline Leukemia Virus Vaccine II-27 Chlamydia, Feline Infectious Peritonitis, and Ringworm Vaccines.............. II-28 Livestock Vaccines..............II-28 Bovine Vaccines.............. II-28 Bovine virus diarrhoea - Mucosal disease (BVD-MD) II-28 Johne's disease..............II-28 Infectious Bovine Rhinotracheitis (IBR) II-28 Blackleg.............. II-28 Neosporosis.............. II-29 Poultry Vaccines..............II-29 Ovine Vaccines.............. II-29 Porcine Vaccines..............II-29 Equine Vaccines.............. II-30 Aquaculture Vaccines..............II-30 A Tabular Analysis on Select Animal Diseases Controlled by Vaccines.............. II-30 Vaccination and Its Reactions..............II-30 Veterinary Vaccines - Latest Breakthroughs II-31 Marker/DIVA Vaccines..............II-31 DNA Vaccines.............. II-31 Gene-Deleted Vaccines..............II-31 Viral-Vectored Vaccines..............II-31
4. NOTES ON SELECT ANIMAL DISEASES II-32 Brucellosis.............. II-32 Tuberculosis.............. II-32 Johne's disease.............. II-32 Spirochete Associated Diseases II-32 Respiratory Disease in Goats, Sheep, and Cattle II-32 Porcine Respiratory Diseases..............II-33 Mastitis.............. II-33 African Swine Fever.............. II-33 Avian Influenza.............. II-33 East Coast Fever.............. II-33 Hemorrhagic Septicemia..............II-34 Foot-And-Mouth Disease..............II-34 Japanese Encephalitis..............II-34 Rift Valley Fever.............. II-34 Equine Virus Infection..............II-34
5. PRODUCT LAUNCHES AND INNOVATIONS..............II-35 MSD Animal Health Unveils PORCILIS PCV ID II-35 Virbac Rolls Out Lepto4 Vaccine..............II-35 Merck Animal Health Rolls Introduces Vaccine against New H3N2 Strain.............. II-35 Zoetis Launches First USDA-Approved Equine Leptospirosis Vaccine, Lepto EQ..............II-35 Ceva Introduces New Porcine Pneumonia Vaccine II-35 Boehringer Ingelheim Rolls Out Two New PRRS Swine Vaccines in Europe.............. II-35 MSD Animal Health Launches INNOVAX®-ILT II-35 Zoetis UK Unveils New Versican® Plus Canine Vaccine Range II-36 Indian Immunologicals to Launch Procine Cysticercosis Vaccine II-36 MSD Animal Health Rolls Out Single-Injection Vaccine for Salmon II-36 Merck Animal Health Launches PORCILIS® PCV M Hyo Single- Injection Vaccine for Piglets II-36 Prevtec Microbia Obtains EU Clearance for Coliprotec F4 Vaccine II-36 Hester Biosciences Rolls Out Two New Vaccines II-36 Boehringer Ingelheim Vetmedica Launches Bovela® BVD Vaccine II-36 Immunologicals Launches First Vaccine against Bluetongue Disease in India.............. II-36 Boehringer Ingelheim Secures EU Clearance for BVD Vaccine Bovela® II-37 Merck Animal Health Rolls Out PRIME PAC PRRS+ Porcine Vaccine II-37 Larad to Sell Poultry IBD Vaccine II-37 AgriLabs Introduces Autogenous Klebsiella Mastitis Vaccine II-37 Boehringer Ingelheim Vetmedica Introduces ULTRA™ Fel-O-Vax® Vaccine for Cats.............. II-37 Boehringer Ingelheim Vetmedica Introduces New Vaccine for Respiratory Diseases in Pigs..............II-37 Valneva Launches Second Vaccine in EB66® Cell Line in South America.............. II-37 Merck Animal Health Launches Combination Vaccine with Longer Immunity Duration for Pigs..............II-37
6. RECENT INDUSTRY ACTIVITY..............II-38 Bayer Teams Up with BioNTech for Development of Innovative Veterinary mRNA Vaccines..............II-38 Harrisvaccines Secures Production Platform Vaccine Licensure from USDA.............. II-38 Orix to Acquire Kyoto Biken..............II-38 Phibro to Take Over Vaccine Assets of MVP Laboratories II-38 Sumitomo Acquires Stake in Shandong Sinder Technology II-38 Sanofi and Boehringer Ingelheim Ink Deal to Swap Business II-38 Merck Animal Health Inks Deal to Take Over Harrisvaccines II-39 Zoetis to Take Over PHARMAQ..............II-39 VitamFero and Bioproperties Execute Co-development and Distribution Deal for Toxoplasmosis Vaccine II-39 Dechra to Buy Chicken Vaccine Maker Genera II-39 Valneva Licenses EB66(r) Cell Line for Vaccines to Jianshun Biosciences for China..............II-39 Eli Lilly Acquires Novartis Animal Health through Elanco II-39 Biogénesis Bagó Begins Construction of New Vaccine Plant in China II-39 Inovio Pharmaceuticals's Subsidiary Divests Animal Health Assets II-40 Braasch Biotech Receives Patent Acceptance in Europe for JH14 - Somatovac® Vaccine.............. II-40 Elanco Inks Agreement to Take Over Lohmann II-40
7. FOCUS ON SELECT GLOBAL PLAYERS..............II-41 Bayer HealthCare AG (Germany)..............II-41 Biogénesis Bagó (Argentina)..............II-41 Boehringer Ingelheim GmbH (Germany) II-42 Ceva Santé Animale (France)..............II-42 Elanco Animal Health (US)..............II-43 Heska Corporation (US)..............II-43 Indian Immunologicals Ltd. (India) II-44 Merck Animal Health (US)..............II-44 Merial Ltd. (US).............. II-44 Virbac SA (France)..............II-45 Zoetis Inc. (US).............. II-45
8. GLOBAL MARKET PERSPECTIVE..............II-47 Table 7: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-47
Table 8: World Historic Review for Veterinary Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-48
Table 9: World 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-49
Table 10: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-50
Table 11: World Historic Review for Companion Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-51
Table 12: World 14-Year Perspective for Companion Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-52
Table 13: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-53
Table 14: World Historic Review for Companion Animal Vaccines by Product Segment - Canine Vaccines and Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-54
Table 15: World 14-Year Perspective for Companion Animal Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Canine Vaccines and Feline Vaccines Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-55
Table 16: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-56
Table 17: World Historic Review for Canine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-57
Table 18: World 14-Year Perspective for Canine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-58
Table 19: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-59
Table 20: World Historic Review for Feline Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-60
Table 21: World 14-Year Perspective for Feline Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-61
Table 22: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-62
Table 23: World Historic Review for Livestock Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-63
Table 24: World 14-Year Perspective for Livestock Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-64
Table 25: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) II-65
Table 26: World Historic Review for Livestock Vaccines by Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)..............II-66
Table 27: World 14-Year Perspective for Livestock Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. II-67
Table 28: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-68
Table 29: World Historic Review for Porcine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-69
Table 30: World 14-Year Perspective for Porcine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-70
Table 31: World Recent Past, Current & Future Analysis for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-71
Table 32: World Historic Review for Bovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-72
Table 33: World 14-Year Perspective for Bovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-73
Table 34: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-74
Table 35: World Historic Review for Poultry Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-75
Table 36: World 14-Year Perspective for Poultry Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-76
Table 37: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-77
Table 38: World Historic Review for Ovine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-78
Table 39: World 14-Year Perspective for Ovine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-79
Table 40: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-80
Table 41: World Historic Review for Equine Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-81
Table 42: World 14-Year Perspective for Equine Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-82
Table 43: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-83
Table 44: World Historic Review for Other Animal Vaccines by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-84
Table 45: World 14-Year Perspective for Other Animal Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-85
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines Market III-1 Dogs and Cats Obesity Vaccines Receive First US Patent III-1 H5N1 Virus: A Conundrum for the US Industry III-2 Product Approvals/Launches..............III-2 Strategic Corporate Developments III-3 Select Major Players..............III-4 B.Market Analytics..............III-7 Table 46: The US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-7
Table 47: The US Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-8
Table 48: The US 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-9
2. EUROPE.............. III-10 A.Market Analysis.............. III-10 Steady Market Growth Expected Due to Superior Livestock Management.............. III-10 Regulations.............. III-10 EU Animal Welfare Strategy..............III-11 Product Approvals/Launches..............III-11 Strategic Corporate Developments III-11 B.Market Analytics..............III-12 Table 49: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-12
Table 50: European Historic Review for Veterinary Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-13
Table 51: European 14-Year Perspective for Veterinary Vaccines by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-14
Table 52: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-15
Table 53: European Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-16
Table 54: European 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-17
2a. FRANCE.............. III-18 A.Market Analysis.............. III-18 Current & Future Analysis..............III-18 Product Launches..............III-18 Select Major Players..............III-18 B.Market Analytics..............III-20 Table 55: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-20
Table 56: French Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-21
Table 57: French 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-22
2b. GERMANY.............. III-23 A.Market Analysis.............. III-23 Current & Future Analysis..............III-23 Product Launches..............III-23 Strategic Corporate Developments III-23 Select Major Players..............III-24 B.Market Analytics..............III-26 Table 58: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-26
Table 59: German Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-27
Table 60: German 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-28
2c. ITALY.............. III-29 Market Analysis.............. III-29 Table 61: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-30
Table 62: Italian Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-31
Table 63: Italian 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-32
2d. THE UNITED KINGDOM..............III-33 A.Market Analysis.............. III-33 Current & Future Analysis..............III-33 Product Launches..............III-33 B.Market Analytics..............III-34 Table 64: The UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-34
Table 65: The UK Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-35
Table 66: The UK 14-Year Perspective for Veterinary Vaccines by Product Group/ Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-36
2e. SPAIN.............. III-37 Market Analysis.............. III-37 Table 67: Spanish Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-38
Table 68: Spanish Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).............. III-39
Table 69: Spanish 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-40
2f. REST OF EUROPE.............. III-41 A.Market Analysis.............. III-41 Current & Future Analysis..............III-41 A Review of Select Regional Markets III-41 The Netherlands..............III-41 Denmark.............. III-41 Russia Mass-Produces Vaccines Against Avian Flu III-43 Product Launch.............. III-43 Strategic Corporate Development III-43 B.Market Analytics..............III-44 Table 70: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-44
Table 71: Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-45
Table 72: Rest of Europe 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-46
3. REST OF WORLD.............. III-47 A.Market Analysis.............. III-47 Current & Future Analysis..............III-47 Focus on Select Markets..............III-47 Asia-Pacific.............. III-47 Table 73: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-48
Table 74: Asia-Pacific Historic Review for Veterinary Vaccines by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-49
Table 75: Asia-Pacific 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for China and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-50 China.............. III-51 Increased Livestock Output and Emerging Pet Industry Lead to Higher Vaccine Demand III-51 Table 76: Chinese Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-52
Table 77: Chinese Historic Review for Veterinary Vaccines by Product Segment - Porcine Vaccines, Poultry Vaccines, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-53
Table 78: Chinese 14-Year Perspective for Veterinary Vaccines by Product Segment - Percentage Breakdown of Dollar Sales for Porcine Vaccines, Poultry Vaccines, and Other Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-54 Growing Pet Industry Holds Promise III-54 Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine..............III-54 Demand for Higher-Quality Swine Fever Vaccine III-55 Demand for Effective PRRS Vaccines by Foreign Manufacturers III-55 FMD Epidemics Cause Increased demand for Vaccine III-55 Effective Rabies Vaccine Needed to Curb Dog Menace III-56 Highly Consolidated Chinese Veterinary Market III-56 Rest of Asia-Pacific..............III-57 India.............. III-57 Animal Vaccines Market to Surge III-57 Table 79: Indian Animal Health Products Market by Segment (2015): Percentage Breakdown of Value Sales for Feed Supplements, Therapeutics and Vaccines (includes corresponding Graph/Chart) III-57 Major Players.............. III-57 New Opportunities Exist despite Well Established Market III-58 Table 80: Indian Veterinary Vaccines Market by Segment (2015): Percentage Breakdown of Value Sales for Companion Animals, Livestock and Poultry (includes corresponding Graph/Chart) III-58 North Korea.............. III-59 Taiwan.............. III-59 Taiwan's Animal Healthcare Industry under Scan III-59 Australia.............. III-59 A Note on Australian Veterinary Therapeutics Market III-59 Sizing the Market..............III-59 Table 81: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-60
Table 82: Rest of Asia-Pacific Historic Review for Veterinary Vaccines Market Analyzed in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-61 Latin America.............. III-62 Current & Future Analysis..............III-62 Table 83: Latin American Recent Past, Current & Future Analysis for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-62
Table 84: Latin American Historic Review for Veterinary Vaccines by Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)..............III-63
Table 85: Latin American 14-Year Perspective for Veterinary Vaccines by Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-64 Canada.............. III-65 Overview of the Canadian Animal Health Industry III-65 Imports and Manufacture of Veterinary Biologics III-65 First to Access E. coli 0157:H7 Vaccine III-65 Product Launches..............III-65 Strategic Corporate Developments III-66 Key Players.............. III-67 B.Market Analytics..............III-68 Table 86: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart) III-68
Table 87: Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart) III-69
Table 88: Rest of World 14-Year Perspective for Veterinary Vaccines by Product Group/Segment - Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-70
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 102 (including Divisions/Subsidiaries - 123)
The United States (23) Canada (2) Japan (6) Europe (41) - France (7) - Germany (7) - The United Kingdom (6) - Italy (3) - Spain (4) - Rest of Europe (14) Asia-Pacific (Excluding Japan) (33) Latin America (10) Middle-East (3) Africa (5)
Download the full report: https://www.reportbuyer.com/product/2070079/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article